Education
About Us
Working with TipRanks
Follow Us
Jan Skvarka Insider Profile
4 Followers
Jan Skvarka, President & Chief Executive Officer at Trillium Therapeutics, holds 0.00 shares in Trillium Therapeutics (Ticker: ~TRIL). Most recently, Jan Skvarka ― shares of Trillium Therapeutics on ― for an estimated value of ―.
Jan Skvarka Trillium Therapeutics (~TRIL)President & Chief Executive Officer
Trillium Therapeutics (~TRIL)
President & Chief Executive Officer
Not Ranked
Jan Skvarka has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Jan Skvarka does not currently own shares as a corporate insider.
A breakdown of Jan Skvarka's holdings
Insider Roles
Jan Skvarka does not currently hold a role as a corporate insider.
Roles that Jan Skvarka holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jan Skvarka
Jan Skvarka's Trading History
List of latest transactions for each holding click on a transaction to see Jan Skvarka's performance on stock
You May Also Like
Jan Skvarka insider profile FAQ
What is the percentage of profitable transactions made by Jan Skvarka?
The percentage of profitable transactions made by Jan Skvarka is ―.
What is the average return per transaction made by Jan Skvarka?
The average return per transaction made by Jan Skvarka is ―.
What stocks does Jan Skvarka hold?
Jan Skvarka holds: ~TRIL stocks.
What was Jan Skvarka’s latest transaction?
Jan Skvarka latest transaction was an Uninformative Buy of ―.
What was Jan Skvarka's most profitable transaction?
Jan Skvarka’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jan Skvarka's role in Trillium Therapeutics?
Jan Skvarka's role in Trillium Therapeutics is President & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.